Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Hilmi

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
European Journal of Cancer (Oxford, England : 1990)|December 6, 2020
Triplet combination of durvalumab, tremelimumab, and paclitaxel in biliary tract carcinomas: Safety run-in results of the randomized IMMUNOBIL PRODIGE 57 phase II trialAlice Boilève, Marc Hilmi, Paul Gougis, et al.
The Journal of Pathology|September 14, 2022
Periostin- and podoplanin-positive cancer-associated fibroblast subtypes cooperate to shape the inflamed tumor microenvironment in aggressive pancreatic adenocarcinomaCindy Neuzillet, Rémy Nicolle, Jérôme Raffenne, et al.
Scientific Reports|April 13, 2021
Prognostic value of intratumoral Fusobacterium nucleatum and association with immune-related gene expression in oral squamous cell carcinoma patientsCindy Neuzillet, Manon Marchais, Sophie Vacher, et al.
European Journal of Cancer (Oxford, England : 1990)|March 3, 2023
Intratumoral microbiome is driven by metastatic site and associated with immune histopathological parameters: An ancillary study of the SHIVA clinical trialMarc Hilmi, Maud Kamal, Sophie Vacher, et al.
Nature Genetics|January 22, 2026
Genomic evolution of pancreatic cancer at single-cell resolutionHaochen Zhang, Palash Sashittal, Elias-Ramzey Karnoub, et al.
Cancers|April 12, 2022
Prognostic Value of <i>Fusobacterium nucleatum</i> after Abdominoperineal Resection for Anal Squamous Cell CarcinomaMarc Hilmi, Cindy Neuzillet, Jérémie H Lefèvre, et al.
Cancer Discovery|February 9, 2026
Myofibroblasts induce neuroplasticity to promote pancreatic inflammation and cancer progressionJérémy Nigri, Wenjun Lan, Melanie L Fung, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2026
Emergency integrative supportive care program for frail patients with advanced pancreatic cancer: A prospective GERCOR ARCAD studyBenoit Rousseau, Marc Hilmi, Antoine Falcoz, et al.
JHEP Reports : Innovation in Hepatology|October 13, 2025
Young-onset biliary tract cancers: Characteristics, treatment patterns, and patient outcomesThomas Pudlarz, Anthony Turpin, Natalia Soledad Tissera, et al.
International Journal of Cancer|November 1, 2023
Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage abdominoperineal resectionAbderaouf Hamza, Julien Masliah-Planchon, Cindy Neuzillet, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
European Journal of Cancer (Oxford, England : 1990)|December 6, 2020
Triplet combination of durvalumab, tremelimumab, and paclitaxel in biliary tract carcinomas: Safety run-in results of the randomized IMMUNOBIL PRODIGE 57 phase II trialAlice Boilève, Marc Hilmi, Paul Gougis, et al.
The Journal of Pathology|September 14, 2022
Periostin- and podoplanin-positive cancer-associated fibroblast subtypes cooperate to shape the inflamed tumor microenvironment in aggressive pancreatic adenocarcinomaCindy Neuzillet, Rémy Nicolle, Jérôme Raffenne, et al.
Scientific Reports|April 13, 2021
Prognostic value of intratumoral Fusobacterium nucleatum and association with immune-related gene expression in oral squamous cell carcinoma patientsCindy Neuzillet, Manon Marchais, Sophie Vacher, et al.
European Journal of Cancer (Oxford, England : 1990)|March 3, 2023
Intratumoral microbiome is driven by metastatic site and associated with immune histopathological parameters: An ancillary study of the SHIVA clinical trialMarc Hilmi, Maud Kamal, Sophie Vacher, et al.
Nature Genetics|January 22, 2026
Genomic evolution of pancreatic cancer at single-cell resolutionHaochen Zhang, Palash Sashittal, Elias-Ramzey Karnoub, et al.
Cancers|April 12, 2022
Prognostic Value of <i>Fusobacterium nucleatum</i> after Abdominoperineal Resection for Anal Squamous Cell CarcinomaMarc Hilmi, Cindy Neuzillet, Jérémie H Lefèvre, et al.
Cancer Discovery|February 9, 2026
Myofibroblasts induce neuroplasticity to promote pancreatic inflammation and cancer progressionJérémy Nigri, Wenjun Lan, Melanie L Fung, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2026
Emergency integrative supportive care program for frail patients with advanced pancreatic cancer: A prospective GERCOR ARCAD studyBenoit Rousseau, Marc Hilmi, Antoine Falcoz, et al.
JHEP Reports : Innovation in Hepatology|October 13, 2025
Young-onset biliary tract cancers: Characteristics, treatment patterns, and patient outcomesThomas Pudlarz, Anthony Turpin, Natalia Soledad Tissera, et al.
International Journal of Cancer|November 1, 2023
Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage abdominoperineal resectionAbderaouf Hamza, Julien Masliah-Planchon, Cindy Neuzillet, et al.
Pageof 5